Immunoreactivity of UBE3C protein was observed in the cytoplasm of glioblastoma tumor cells (Fig. 1C), and very low levels of UBE3C expression were detected in non-tumor tissues compared to glioma tissues. Here, UBE3C is linked to central nervous system cancer.